SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

LMAT

Lemaitre Vascular Inc.
NASDAQHealth Care

Latest close: 80.82 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 5, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 4, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,79514 flagged findings
Reported transactions (Form 4)80since Feb 26, 2026
Corporate events (8-K)30since Nov 10, 2016

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06share offering or dilution eventrecentOpen filing ↗
    “…net 31,674 33,089 Deferred tax assets 741 759 Other assets 4,970 4,906 Total assets $ 629,526 $ 615,690 Liabilities and…”
    +1 more passage from the same document
    • “…2026 $ 419 As of March 31, 2026, a summary of the tax years that remain subject to examination in the Company’s taxing…”
  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…to common shareholders for the periods indicated because including them would have an anti-dilutive effect: Three months ended…”
    +1 more passage from the same document
    • “…to common shareholders for the periods indicated because including them would have an anti-dilutive effect: Three months ended March…”
  • 2026-02-26share offering or dilution eventrecentOpen filing ↗
    “…and regulations that apply to our human tissue cryopreservation services, we cannot guarantee that is the case, and any failure to…”
    +1 more passage from the same document
    • “…penalties, any of which would have a negative impact on our ability to conduct our business and our operating results. Risks…”
  • 2026-02-26capital return (buybacks/dividends)recentOpen filing ↗
    “…prospects; • changes in our growth rates; • our announcements or our competitors’ announcements of new products; • the public’s…”
    +1 more passage from the same document
    • “…million, $ 4.9 million, and $ 2.7 million, respectively. The Company repurchases shares of its common stock in order to cover any…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,795)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

1,795 filings on record, the oldest from Oct 18, 06.

Listing the 25 most recent filings of the 1,795 on record.

8-Ks, explained

Stress9Structure31Governance32
  • Governance3 senior executive changes2025 – 2026show all 3hide
    • Oct 15, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 14, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 13, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Dec 19, 24StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗
  • Aug 26, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 3, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Nov 1, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 23, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 28, 22StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Dec 2, 21StructureA material agreement was terminated8-K 1.02 ↗
  • Sep 1, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 16, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 9, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 24, 20StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

10 older filings not shown · The record reaches back to Dec 26, 06.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 17, 20StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
  • Feb 25, 14StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • May 20, 11StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Dec 3, 10StressRestructuring plan with committed costs8-K/A 2.05 ↗
  • Oct 28, 10StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Aug 8, 08StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 31, 07StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 24, 07StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 9 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

show one more holderhide
  • First Trust Portfolios L.P.5.2%Jun 30, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jul 29, BRIDGET A ROSS filed notice of intent to sell up to $449K. That is about 0.02% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • May 8, 26Sell$313KTrent G KamkeSenior V. P., Operations↗
  • May 8, 26Sell$3.0MGeorge W LeMaitreChairman and CEO↗
  • May 7, 26Sell$434KLawrence J Jasinski↗
  • May 7, 26Sell$560KBridget A Ross↗
  • May 7, 26Sell$2.0MGeorge W LeMaitreChairman and CEO↗
  • Mar 11, 26Sell$357KDavid B RobertsPresident and Director↗
  • Mar 11, 26Sell$285KTrent G KamkeSenior V. P., Operations↗
  • Mar 2, 26Sell$6.0MGeorge W LeMaitreChairman and CEO↗
  • Feb 27, 26Sell$904KDavid B RobertsPresident and Director↗
  • Feb 27, 26Sell$115KTrent G KamkeSenior V. P., Operations↗
  • Feb 26, 26Sell$16.0MGeorge W LeMaitreChairman and CEO↗
Stock compensation, tax and giftsshow the 29 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 1, 26Compensation$167KJohn A Roush↗
  • Jun 4, 26Giftamount n/aGeorge W LeMaitreChairman and CEO↗
  • Jun 4, 26Compensationamount n/aGeorge W LeMaitreChairman and CEO↗
  • May 7, 26Compensation$50KLawrence J Jasinski↗
  • May 7, 26Compensation$50KLawrence J Jasinski↗
  • May 7, 26Compensation$87KLawrence J Jasinski↗
  • May 7, 26Compensation$167KBridget A Ross↗
  • May 7, 26Compensation$76KBridget A Ross↗
  • Apr 22, 26Compensation$104KJoseph P Pellegrino JR↗
  • Mar 11, 26Compensation$93KTrent G KamkeSenior V. P., Operations↗
  • Mar 10, 26Compensationamount n/aDorian Paul LeBlancChief Financial Officer↗
  • Mar 10, 26Tax$10KDorian Paul LeBlancChief Financial Officer↗
  • Mar 2, 26Giftamount n/aGeorge W LeMaitreChairman and CEO↗
  • Feb 26, 26Compensationamount n/aGeorge W LeMaitreChairman and CEO↗
  • Feb 26, 26Compensationamount n/aGeorge W LeMaitreChairman and CEO↗
  • Feb 26, 26Tax$56KGeorge W LeMaitreChairman and CEO↗
  • Feb 26, 26Compensationamount n/aDavid B RobertsPresident and Director↗
  • Feb 26, 26Compensationamount n/aDavid B RobertsPresident and Director↗
  • Feb 26, 26Compensationamount n/aDavid B RobertsPresident and Director↗
  • Feb 26, 26Tax$15KDavid B RobertsPresident and Director↗
  • Feb 26, 26Tax$1KDavid B RobertsPresident and Director↗
  • Feb 26, 26Compensationamount n/aTrent G KamkeSenior V. P., Operations↗
  • Feb 26, 26Compensationamount n/aTrent G KamkeSenior V. P., Operations↗
  • Feb 26, 26Tax$11KTrent G KamkeSenior V. P., Operations↗
  • Feb 26, 26Compensationamount n/aJoseph P Pellegrino JR↗
  • Feb 26, 26Compensationamount n/aJoseph P Pellegrino JR↗
  • Feb 26, 26Compensationamount n/aLawrence J Jasinski↗
  • Feb 26, 26Compensationamount n/aLawrence J Jasinski↗
  • Feb 26, 26Compensationamount n/aJohn James O'Connor↗

The full record holds 482 transactions and goes back to Mar 7, 22.

Its sector and its market

Lemaitre Vascular Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Lemaitre Vascular Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Lemaitre Vascular Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,795 documents on file, from Oct 18, 2006 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.